Hikma Pharmaceuticals (HIK)

 

Latest News

Director Deals - Hikma Pharmaceuticals PLC (HIK)

John Castellani, Non Executive Director, bought 1,000 shares in the company on the 22nd May 2018 at a price of 1376.95p. T...

Director/PDMR Shareholding

RNS Number: 0225P Hikma Pharmaceuticals Plc 23 May 2018 Notification and public disclosure of transactions by persons discharging managerial responsibilities 1 Details of the person discharging managerial responsibilities / person closely associated a) Name John Castellani 2 Reason for the notification a) Position/status Non-Executive Director b) Initial notificatio...

AGM Results

RNS Number: 6033O Hikma Pharmaceuticals Plc 18 May 2018 Hikma Pharmaceuticals PLC Voting Results of 2018 Annual General Meeting LONDON, 18 May 2018 - Hikma Pharmaceuticals PLC (the " Company ") announces its Annual General Meeting (" AGM "), held at Sofitel St James, 6 Waterloo Place, London SW1Y 4AN on 18 May 2018 commenced at 10:00 am...

Broker Forecast - Numis issues a broker note on Hikma Pharmaceuticals PLC

Numis today downgrades its investment rating on Hikma Pharmaceuticals PLC (LON:HIK) to add (from buy) and raised...

All News

DateHeadlineSource
23-05-18Director Deals - Hikma Pharmaceuticals PLC (HIK)StockMarketWire
23-05-18Director/PDMR ShareholdingRNS
18-05-18AGM ResultsRNS
18-05-18Broker Forecast - Numis issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
18-05-18UK stocks open 0.2% lower as AstraZeneca disappointsStockMarketWire
18-05-18Hikma Pharmaceuticals reiterates full-year guidanceStockMarketWire
18-05-18Trading StatementRNS
17-05-18Director/PDMR ShareholdingRNS
17-05-18Director/PDMR ShareholdingRNS
15-05-18Director Deals - Hikma Pharmaceuticals PLC (HIK)StockMarketWire
15-05-18Director Deals - Hikma Pharmaceuticals PLC (HIK)StockMarketWire
15-05-18Director/PDMR ShareholdingRNS
03-05-18Hikma launches Methotrexate InjectionRNS
01-05-18Total Voting RightsRNS
01-05-18Broker Forecast - Citigroup issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
26-04-18Holding(s) in CompanyRNS
25-04-18Block listing Interim ReviewRNS
24-04-18Hikma signs agreement to distribute, market Rovi cardiovascular productStockMarketWire
24-04-18Hikma expands licensing agreement with RoviRNS
20-04-18Hikma Pharmaceuticals US unit launches treatment for breast cancer sufferersStockMarketWire
20-04-18Hikma launches injection to reduce severity of cardiomyopathyStockMarketWire
20-04-18Hikma launches Dexrazoxane for InjectionRNS
19-04-18Annual Financial Report and Notice of AGMRNS
10-04-18Director/PDMR ShareholdingRNS
03-04-18Total Voting RightsRNS
29-03-18Hikma launch-Palonosetron Hydrochloride InjectionRNS
20-03-18Hikma Pharmaceuticals subsidiary launches generic HIV treatmentStockMarketWire
20-03-18Broker Forecast - Peel Hunt issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
20-03-18Hikma has launched Ritonavir Tablets USPRNS
19-03-18Director Deals - Hikma Pharmaceuticals PLC (HIK)StockMarketWire
19-03-18Director Deals - Hikma Pharmaceuticals PLC (HIK)StockMarketWire
19-03-18Director/PDMR ShareholdingRNS
15-03-18Broker Forecast - Morgan Stanley issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
15-03-18Broker Forecast - Citigroup issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
15-03-18Broker Forecast - Jefferies International issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
15-03-18Broker Forecast - JP Morgan Cazenove issues a broker note on Hikma Pharmaceuticals PLCStockMarketWire
14-03-18Expected boost in oil output weighs on FTSEStockMarketWire
14-03-18Upbeat industrial data from China boosts the resources sectorStockMarketWire
14-03-18Hikma swings to loss as increased competition pressures generics businessStockMarketWire
14-03-18Final ResultsRNS

RSS feeds

  • Editorial news feed for LSE:HIK Editorial
  • Regulatory news feed for LSE:HIK Regulatory